Annual CFO
$25.89 M
+$15.21 M+142.50%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual cash flow from operations is $25.89 million, with the most recent change of +$15.21 million (+142.50%) on December 31, 2023.
- During the last 3 years, GYRE annual CFO has risen by +$5.14 million (+24.75%).
- GYRE annual CFO is now at all-time high.
Performance
GYRE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$1.73 M
+$7.22 M+131.42%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly cash flow from operations is $1.73 million, with the most recent change of +$7.22 million (+131.42%) on September 30, 2024.
- Over the past year, GYRE quarterly CFO has dropped by -$1.63 million (-48.63%).
- GYRE quarterly CFO is now -83.43% below its all-time high of $10.42 million, reached on March 1, 2023.
Performance
GYRE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$2.48 M
-$5.86 M-70.27%
September 30, 2024
Summary
- As of February 7, 2025, GYRE TTM cash flow from operations is $2.48 million, with the most recent change of -$5.86 million (-70.27%) on September 30, 2024.
- Over the past year, GYRE TTM CFO has dropped by -$23.41 million (-90.43%).
- GYRE TTM CFO is now -90.43% below its all-time high of $25.89 million, reached on December 31, 2023.
Performance
GYRE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GYRE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +142.5% | -48.6% | -90.4% |
| 3 y3 years | +24.8% | -83.4% | -76.2% |
| 5 y5 years | +24.8% | -83.4% | -76.2% |
GYRE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +142.5% | -83.4% | +131.4% | -90.4% | at low |
| 5 y | 5-year | at high | +142.5% | -83.4% | +131.4% | -90.4% | at low |
| alltime | all time | at high | +142.5% | -83.4% | +131.4% | -90.4% | at low |
Gyre Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.73 M(-131.4%) | $2.48 M(-70.3%) |
| Jun 2024 | - | -$5.49 M(-290.5%) | $8.33 M(-54.6%) |
| Mar 2024 | - | $2.88 M(-14.2%) | $18.36 M(-29.1%) |
| Dec 2023 | $25.89 M | $3.36 M(-55.7%) | $25.89 M(+14.9%) |
| Sep 2023 | - | $7.58 M(+67.3%) | $22.53 M(+50.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $4.53 M(-56.5%) | $14.95 M(+43.5%) |
| Mar 2023 | - | $10.42 M(+15.8%) | $10.42 M(+15.8%) |
| Dec 2022 | $10.68 M(-48.6%) | - | - |
| Mar 2022 | - | $9.00 M | $9.00 M |
| Dec 2021 | $20.76 M | - | - |
FAQ
- What is Gyre Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Gyre Therapeutics?
- What is Gyre Therapeutics annual CFO year-on-year change?
- What is Gyre Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly CFO year-on-year change?
- What is Gyre Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Gyre Therapeutics?
- What is Gyre Therapeutics TTM CFO year-on-year change?
What is Gyre Therapeutics annual cash flow from operations?
The current annual CFO of GYRE is $25.89 M
What is the all time high annual CFO for Gyre Therapeutics?
Gyre Therapeutics all-time high annual cash flow from operations is $25.89 M
What is Gyre Therapeutics annual CFO year-on-year change?
Over the past year, GYRE annual cash flow from operations has changed by +$15.21 M (+142.50%)
What is Gyre Therapeutics quarterly cash flow from operations?
The current quarterly CFO of GYRE is $1.73 M
What is the all time high quarterly CFO for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly cash flow from operations is $10.42 M
What is Gyre Therapeutics quarterly CFO year-on-year change?
Over the past year, GYRE quarterly cash flow from operations has changed by -$1.63 M (-48.63%)
What is Gyre Therapeutics TTM cash flow from operations?
The current TTM CFO of GYRE is $2.48 M
What is the all time high TTM CFO for Gyre Therapeutics?
Gyre Therapeutics all-time high TTM cash flow from operations is $25.89 M
What is Gyre Therapeutics TTM CFO year-on-year change?
Over the past year, GYRE TTM cash flow from operations has changed by -$23.41 M (-90.43%)